1. Introduction {#s0005}
===============

According to World Health Organization, about 520,000 new cases of cervical cancer were diagnosed annually worldwide, with over 85% from developing countries ([@bb0050]). In Vietnam, the incidence of cervical cancer is 16 per 100,000 women/year; annually there are 6500 new cases and about 3000 women will die from cervical cancer. In contrast, cervical cancer incidence in developed countries is substantially lower due to the effective and efficient organized mass screening programs and appropriate interventions after detection of abnormal cases ([@bb0005]; [@bb0045]). Cervical cancer has a long natural history and progression interval. Early detection of precancerous lesions by conventional screening and diagnosis modalities such as cervical cytology, colposcopy, cervical biopsy, endocervical curettage allows for treatment of these precancerous lesions before progression to invasive cancers.

Pap smear screening has markedly reduced mortality from cervical cancer in developed countries. In Vietnam there has been many efforts for cervical cancer screening using routine Pap smears in major centers; however, the cytologic screening coverage is still very low outside of the urban regions. Moreover, VIA is considered as an attractive alternative to cytology-based screening in low-resource settings, it is a simple and cost-effective technique acceptable to women and providers. High-risk HPV DNA has been identified in 99.9% of invasive cervical cancers specimens ([@bb0035]). The sensitivity and specificity of VIA and HPV when used sequentially were 63.6 and 81.9%, respectively ([@bb0015]). This study aims to determine the diagnostic values of VIA and Pap smear in a cervical cancer screening program at a rural community in Thua Thien Hue Province, Vietnam.

2. Subjects and methods {#s0010}
=======================

This cross-sectional descriptive study on 1034 married or sexually active reproductive-age women (15--49 years) from Thua Thien Hue Province was carried out from September 2012 to May 2013. Women who had a prior hysterectomy, who were menstruating, pregnant or in the post-partum period, used vaginal douching 24 h before examination, had existing precancerous-cancerous cervical lesions or a history of gynecologic malignancies, or had received pelvic radiation were excluded from the study.

Sample size was calculated for rate estimate investigation:$$n = Z_{\alpha/2}^{2}\frac{p\left( {1 - p} \right)}{\Delta^{2}}$$with the prevalence p = 12%, Δ = 0,02, α = 0,05, Z~*α*/2~ = 1,96, minimum sample size is 1015 women. In total, 1100 women were invited for gynecologic examination.

The study was carried-out in 3 districts that were representative of geographic and socio-economic characteristics for Thua Thien Hue Province: City of Hue (at An Hoa, An Cuu, An Dong, and Phuong Duc Communes), Nam Dong District (at Khe Tre, Huong Loc, and Huong Huu Communes), and Phu Vang District (at Phu Mau, Vinh Ha, Phu Dien, and Vinh Thanh Communes). One hundred women in the eligible age group from each commune were randomly selected, and 66 women were excluded according to exclusion criteria, resulting in the final sample size of 1034 women.

All individuals enrolled in the study were subjected to gynecologic examination and conventional Pap smear, followed by visual inspection with acetic acid, as described elsewhere ([@bb0050]). The abnormal cytologic results include ASC-US/-H, AGUS, LSIL, HSIL, and invasive cancer.

Women who had abnormal VIA and/or had a positive cytology result were invited for a second visit at the Hue University Hospital for colposcopy. If there was lesion classified as abnormal or suspicious for invasive cancer according to the nomenclature of 2002 International Federation of Colposcopy and Cervical Pathology, a biopsy was performed ([@bb0015]). Histopathological results were assessed according to the WHO classification. Histologic confirmed CIN2+ served as gold standards for diagnostic values analysis.

Data were entered and statistical analysis was performed using the software SPSS 19.0. Ethical approval for study protocol was obtained from the Ethic Committee for Biomedical Researches of Hue University of Medicine and Pharmacy.

3. Results {#s0015}
==========

3.1. General characteristics of study sample {#s0020}
--------------------------------------------

From the 1034 women included into the final evaluation, there were 87 women having VIA+, and 48 women having ACS-US+ cytologic findings. General characteristics of study sample were described in [Table 1](#t0005){ref-type="table"}.Table 1General characteristics of study sample.Table 1Characteristicsn = 1132%Age18--1920.220--2917615.530--3948442.840--4947041.5  Level of literacyIlliteracy12811.3Primary to high school87677.4College/university12811.3  OccupationFarmer31127.5Trader32228.4Officials13411.8Housewife21519.0Others15013.3  Current number of children090.81--257550.8≥354848.4

3.2. Diagnostic value of VIA {#s0025}
----------------------------

In total, 123 subjects were positive from VIA and/or cervical cytology and/or HPV DNA testing and were invited for colposcopy examination and biopsy. CIN2+ lesions were identified from 69 subjects, which resulted in a biopsy confirmed rate of 56.1%. Abnormal VIA results were recorded in 87 cases (7.7%). [Table 2](#t0010){ref-type="table"} describes the distribution of VIA findings according to histopathological results. Using histologic confirmed CIN2+ as a gold standard, the sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) of VIA were 88.8%, 43.8%, 63.4%, 51.2% and 83.3%, respectively.Table 2VIA and histopathological results.Table 2Histologic VIACIN 2CIN 3NegativeTotalVIA (+)25144887VIA (−)273636Total521754123[^1]

3.3. Diagnostic value of Pap smear {#s0030}
----------------------------------

Among 69 cases having CIN2+; 40 out of 48 cases presented with abnormal Pap smear, accounting for 83.3%. Diagnostic match rate between cytologic LSIL and HSIL and histopathology was 100% (see [Table 3](#t0015){ref-type="table"}).Table 3Distribution of Pap smear and pathology results.Table 3PAPnPathologyDiagnostic match rate between Pap and pathology (%)Benign changesCIN2+Normal/Benign change75462961.3ASCUS/H2852382.1AGUS113872.7LSIL707100HSIL202100Cancer000100**Total1234869**

From [Table 4](#t0020){ref-type="table"}, diagnostic values of Pap smear were 58.0%, 85.2%, 69.9%, 83.3% and 61.3% for its sensitivity, specificity, accuracy, PPV and NPV, respectively.Table 4Results of Pap smear and pathology.Table 4Pathology (+)Pathology (−)TotalPap (+)408**48**Pap (−)2946**75Total6954123**[^2]

4. Discussion {#s0035}
=============

This study sample is geographically representative of urban, mountainous and coastal regions of the Thua Thien Hue Province, Vietnam. The pelvic examination, HPV, cytologic sampling, and VIA were performed at the Commune Health Centers, the lowest-level health facility within the health system of Vietnam. Thereafter samples were sent back to Hue University Hospital for processing and interpretation. Therefore, the study setting reflected the real-world environment of cytologic testing, especially the performance of VIA at the grass-roots level.

Diagnostic values of Pap smear were 58.0%, 85.2%, 69.9%, 83.3% and 61.3% for its sensitivity, specificity, accuracy, PPV and NPV, respectively. This means that Pap smears are needed on VIA+ patients because VIA is very sensitive, but with a lower PPV. Pap smear has a high PPV which can determine who truly had CIN2+. VIA from this data also has a good NPV.

Diagnostic values of Pap smear were in expected range as reported by other authors. Its sensitivity for cervical lesion detection seems to be much lower than those of VIA, which was confirmed by many previous studies.

A study on 2199 women in Harare, Zimbabwe, used VIA, Pap smear, and HPV as cervical screening tests, with HGSIL/CIN II-III as the reference threshold of disease. The net sensitivity and specificity of VIA and HPV when used sequentially were 63.6 and 81.9%, respectively, compared to 43.3 and 91%, respectively, when Pap smears were followed by HPV testing. VIA followed by the Pap smear yielded a net sensitivity of 37.5% and net specificity of 94.3%. The authors concluded that the use of VIA followed by HPV could yield fewer false positives than the use of VIA alone ([@bb0010]).

In other studies, the combination of PAP smear and HPV testing offers clear advantages over single cytology with SE of 90.0%, SP 50.0%, PPV 52.9% and NPV 88.9% at first follow-up, and 100% SE and 100% NPV at the second follow-up visit ([@bb0025]). In 2008, Chao et al. also evaluated the complementary value of HPV testing to Pap smear in Taiwan and concluded that the combination of two methods improved the sensitivity by 15.3% ([@bb0020]). Another study in Kenya on 653 women showed a sensitivity for CIN2 or higher and specificity were 83.3% and 94.6%, respectively, for Pap smear; 73.3% and 80.0% for VIA; and up to 94.4% and 73.9% for high-risk HPV testing ([@bb0030]).

To the best of our knowledge, this study is among the rare field studies from Vietnam to test the feasibility and validity of VIA performed after cervical sampling for Pap smear. It showed that even after being cytologically sampled, the cervix is still suitable for implementing VIA with the purpose of cervical screening, if the of mucus and blood removal step before applying acetic acid is observed. This finding has been long confirmed in the 2003 Pan American Health Organization\'s critical review on the validity of VIA ([@bb0040]).

The limitations of this study include the rather small number of subjects involved, and due to the limited resources, colposcopy has been carried out only on subjects having abnormal cytologic and/or VIA findings, and not among those having negative screening results for a better quality assurance.

In conclusion, VIA yielded high sensitivity, but its accuracy is limited during cervical cancer screening for pre-cancerous lesions. The Pap smear has acceptable sensitivity and specificity, but its false-negative rate is high. Based on this finding, screening at community settings in Vietnam should include a combination of VIA, followed by confirmatory Pap test to increase the efficiency of screening.
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